Sophie Papa, PhD, MBBS, MRCP, medical oncologist, Clinical Academic Group, Department of Research Oncology, King’s College London, discusses leukapheresis manufacturing approach in head and neck cancer.
Sophie Papa, PhD, MBBS, MRCP
Advertisement
Articles by Sophie Papa, PhD, MBBS, MRCP
Sophie Papa, PhD, MBBS, MRCP, medical oncologist, Clinical Academic Group, Department of Research Oncology, King’s College London, discusses the impact of a recent study of chimeric antigen receptor (CAR) T cells in head and neck squamous cell carcinoma.
Sophie Papa, PhD, MBBS, MRCP, King’s College London in the United Kingdom, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with head and neck cancer.
Sophie Papa, PhD, MBBS, MRCP, King’s College London in the United Kingdom, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with head and neck cancer.
Advertisement
Latest Updated Articles
Dr. Papa on CAR T-Cell Therapy for Head and Neck CancerPublished: April 6th 2017 | Updated:
Dr. Papa on Challenges of CAR T-Cell Therapy in Head and Neck CancerPublished: April 1st 2017 | Updated:
Dr. Papa on the Impact of CAR T Cell Trial in Head and Neck CancerPublished: April 27th 2017 | Updated:
Dr. Papa on Leukapheresis Manufacturing Approach in Head and Neck CancerPublished: May 18th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
Oncology Fellows Presents a New Drug Cheat Sheet for Fellows
3
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
4
Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant
5